Protagen Protein Services GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Protagen Protein Services GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11289
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:15
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Protagen Protein Services GmbH (PPS), a subsidiary of Zukunftsfonds Heilbronn GmbH & Co KG is a contract research organization that offers protein analytics. The organization offers services such as services for biopharmaceuticals, protein characterization, biosimilars services, and analytical methods, among others. Its protein characterization services include protein modification, bioassay, protein quantification, protein primary structure, and protein impurities. PPS’s services for biosimilars comprise detailed structural characterization and support in cell line and process development, among others. The organization partners with research institutes to offer its services to clients. It works in partnership with other research institutions and pharmaceutical companies. PPS is headquartered in Heilbronn, Germany.

Protagen Protein Services GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deal Details 9
Partnerships 9
Protagen Protein Services, Assign International, Aurigon, Celonic and PharmaLex Form Joint Venture 9
Merger 10
Protagen Protein Services Merges with Panatecs 10
Acquisition 11
Zukunftsfonds Heilbronn Acquires Protagen Protein Services From Protagen 11
Protagen Protein Services GmbH – Key Competitors 12
Protagen Protein Services GmbH – Key Employees 13
Protagen Protein Services GmbH – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Appendix 15
Methodology 15
About GlobalData 15
Contact Us 15
Disclaimer 15

List of Tables
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Protagen Protein Services, Assign International, Aurigon, Celonic and PharmaLex Form Joint Venture 9
Protagen Protein Services Merges with Panatecs 10
Zukunftsfonds Heilbronn Acquires Protagen Protein Services From Protagen 11
Protagen Protein Services GmbH, Key Competitors 12
Protagen Protein Services GmbH, Key Employees 13
Protagen Protein Services GmbH, Other Locations 14

List of Figures
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Protagen Protein Services GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Protagen Protein Services GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Orion New Zealand Ltd:企業の戦略的SWOT分析
    Orion New Zealand Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Posco Daewoo Corporation (047050)-石油・ガス分野:企業M&A・提携分析
    Summary Posco Daewoo Corporation (Posco Daewoo), formally known as Daewoo International Corporation, is an international trading and investment company. It is involved in international trade, resource development and project organizing businesses. The company’s operational activities include export …
  • Syngene International Ltd (SYNGENE):製薬・医療:M&Aディール及び事業提携情報
    Summary Syngene International Ltd (Syngene), a subsidiary of Biocon Ltd, is a clinical research and manufacturing organisation. The organisation offers research, development and manufacturing programs. It provides discovery chemistry, discovery biology, large molecule development, safety assessment, …
  • Spindletop Oil & Gas Co (SPND):石油・ガス:M&Aディール及び事業提携情報
    Summary Spindletop Oil & Gas Co (Spindletop Oil & Gas) is an oil and gas exploration and production company. The company explores, develops and produces crude oil and natural gas in North America. It owns and maintains natural gas pipeline in Texas. Spindletop Oil & Gas also operates various gas pip …
  • Salem Media Group, Inc. (SALM):企業の財務・戦略的SWOT分析
    Salem Media Group, Inc. (SALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Sirona Biochem Corp (SBM):製薬・医療:M&Aディール及び事業提携情報
    Summary Sirona Biochem Corp (Sirona Biochem) is a biotechnology company that discovers and develops therapeutics, cosmeceuticals and biological ingredients. The company develops drugs for diabetes and cancer. It provides cosmeceutical programs such as development of anti-aging and depigmenting agent …
  • BARMER GEK:企業の戦略的SWOT分析
    BARMER GEK - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Tidewater Inc (TDW):企業の財務・戦略的SWOT分析
    Summary Tidewater Inc (Tidewater) is an an petroleum service company that offers offshore supply vessels and marine support services. The company's services include transport and supply of offshore material; anchor handling, towing and positioning; construction support; well stimulation, FPSO suppor …
  • Broadwind Energy Inc (BWEN):電力:M&Aディール及び事業提携情報
    Summary Broadwind Energy Inc (Broadwind) is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. It offers a wide range of products from gears and gearing systems, to wind turbine towers, fabrications and industrial weldments. The …
  • POSCO:企業のM&A・事業提携・投資動向
    POSCO - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's POSCO Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisin …
  • ProMetic Life Sciences Inc (PLI):企業の財務・戦略的SWOT分析
    ProMetic Life Sciences Inc (PLI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Cochlear Ltd (COH):医療機器:M&Aディール及び事業提携情報
    Summary Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions. It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage. Its major products include c …
  • Innergex Renewable Energy Inc (INE):企業の財務・戦略的SWOT分析
    Innergex Renewable Energy Inc (INE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Harbin Electric International Co Ltd:企業の戦略的SWOT分析
    Harbin Electric International Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Abu Dhabi National Energy Co (TAQA):企業の財務・戦略的SWOT分析
    Abu Dhabi National Energy Co (TAQA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Save The Children Federation Inc:企業の戦略的SWOT分析
    Save The Children Federation Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Grupa Zywiec S.A.:企業の戦略・SWOT・財務情報
    Grupa Zywiec S.A. - Strategy, SWOT and Corporate Finance Report Summary Grupa Zywiec S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Phylogica Ltd (PYC):企業の財務・戦略的SWOT分析
    Summary Phylogica Ltd (Phylogica) is a biotechnology company that develops intracellular biological therapeutics. The company utilizes proprietary phylomer peptide libraries and screening methodologies to identify unique peptide drug candidates. Its products include libraries and peptides. Phylogica …
  • BioSyent Inc (RX):企業の財務・戦略的SWOT分析
    Summary BioSyent Inc (BioSyent), formerly Hedley Technologies Inc is a specialty pharmaceutical company that offers in-licensing or acquiring innovative pharmaceutical products and technologies to enhance human health. The company’s products include Aguettant System for pre-filled syringes, FeraMAX …
  • Air Water Inc (4088):企業の財務・戦略的SWOT分析
    Air Water Inc (4088) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆